In Hong Kong, as of June 23, 2024, UnitedHealth Group (UNH) has seen its stock price drop by 10% over the past week, bringing it to $330.83. It’s important to note, perhaps, that the stock’s current standing comes amidst moderate operating results and financial health. There’s a sort of moderate rating associated with it, and honestly, it feels like it might just be an appropriate price point.
UNH has faced challenges in recent months, despite its substantial presence in the U.S. healthcare landscape. The company reported earnings for the second quarter of 2025 that fell short of expectations, which has caused some concern among investors. A major factor in this downturn was the unexpectedly rapid increase in medical costs—particularly within the Medicare Advantage sector—putting further strain on profits. On a slightly brighter note, UNH did report a solid 12% year-on-year sales growth in the third quarter, which is encouraging, I suppose. Still, this positive news is undercut by lingering worries about cost trends, regulatory hurdles, and the company’s ability to manage escalating expenses effectively.
The ratings we have reflect this complex situation.
Looking ahead, stock markets can be quite volatile—just think back to the highs and lows in 2008 or even 2020. This volatility is inevitable. The allocation approach of a wealth management partner outlines how to navigate these ups and downs effectively.
Now, let’s delve into some specifics while also providing a bit of background: UnitedHealth, with a market capitalization of around $30 billion, offers a range of medical services, including consumer health benefit plans and pharmacy care programs.
Overall Rating: Moderate
A quick comparison of UNH’s valuation against the broader market shows some interesting insights—that’s worth checking.
- UnitedHealth’s growth rate over the last three years sits at approximately 11.4%.
- In the last year, revenue has increased by 10%, rising from $394 billion to $435 billion.
- Furthermore, quarterly revenue experienced a 12.2% growth, reaching $113 billion, up from $101 billion a year prior.
Profitability Indicators
- Operating income averaged $2.6 billion over the last 12 months, marking an operating profit margin of 6.1%.
- Cash flow margins stood at 4.8%, producing about $2.1 billion in operating cash flow during this period.
- Net profits climbed to around $1.8 billion, with a net profit margin of approximately 4.0%.
Financial Stability
- As of the most recent quarter, UNH held $80 billion in debt, with a market capitalization of about $300 billion, leading to a debt-to-equity ratio of 27.0%.
- Total cash, including equivalents, stood at $3.1 billion out of total assets of $315 billion, reflecting a cash and deposit ratio of 9.7%.
Resilience in Economic Downturns
Interestingly, UNH demonstrated a bit more resilience compared to the S&P 500 during various economic hardships. To evaluate this, we can look at both stock price declines and recovery speeds.
During the inflation spike of 2022, for instance, UNH’s shares fell 19.3% from a high of $555.15 on October 31, 2022, to $447.75 on July 13, 2023, while the S&P 500 dropped by 25.4%. Still, UNH rebounded to its pre-crisis peak by July 17, 2024, and reached a high of $625.25 on November 11, 2024, although it’s now back at $330.83.
Looking back further, in the wake of the COVID-19 pandemic, UNH stock plummeted 36.2% from a high of $305.31 on February 19, 2020, down to $194.86 by March 23, 2020, compared to a 33.9% decline for the S&P 500. Yet, it made a full recovery by June 1, 2020.
During the global financial crisis of 2008, UNH saw a massive drop of 72.4%, falling from $58.99 on December 21, 2007, to $16.30 on November 20, 2008, while the S&P 500 experienced a 56.8% decline. Remarkably, UNH bounced back to its pre-crisis price by April 2, 2012.
However, it’s crucial to acknowledge that risks extend beyond market crashes. Stock prices can fall even in otherwise favorable conditions—it’s important to consider factors like earnings reports, business updates, and changes in outlook. Understanding past recovery trends can provide valuable insights.
Lastly, the best strategies tend to involve a selection of high-quality stocks that have shown resilience against various benchmarks, possibly offering a smoother investment experience.
